Financial Performance - The company's operating revenue for 2022 was RMB 1,049,926,309.11, representing a year-on-year increase of 1.09% compared to RMB 1,038,587,042.22 in 2021[21]. - The net profit attributable to shareholders of the listed company reached RMB 97,308,534.73, marking a significant increase of 30.12% from RMB 74,782,577.41 in the previous year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 64,836,695.88, which is a substantial increase of 101.90% compared to RMB 32,113,156.98 in 2021[21]. - The net cash flow from operating activities was RMB 150,555,939.16, reflecting a remarkable increase of 163.58% from RMB 57,119,822.51 in the previous year[21]. - Basic earnings per share for 2022 were CNY 0.97, up from CNY 0.75 in 2021, marking a growth of 29.33%[23]. - The diluted earnings per share also stood at CNY 0.97 for 2022, consistent with the basic earnings per share[23]. - The weighted average return on equity increased to 8.67% in 2022, compared to 7.1% in 2021, an increase of 1.57 percentage points[23]. - The company reported a significant increase in the return on equity after excluding non-recurring items, reaching 5.78% in 2022, up from 3.05% in 2021[23]. Assets and Liabilities - As of December 31, 2022, the total assets of the company amounted to RMB 1,586,078,143.77, an increase of 2.91% from RMB 1,541,167,018.23 at the end of 2021[22]. - The net assets attributable to shareholders of the listed company were RMB 1,165,000,581.16, which is a growth of 7.95% compared to RMB 1,079,220,387.42 at the end of 2021[22]. - Total liabilities decreased to CNY 421,077,562.61 in 2022 from CNY 461,946,630.81 in 2021, a reduction of about 8.8%[177]. - Shareholders' equity rose to CNY 1,165,000,581.16 in 2022, compared to CNY 1,079,220,387.42 in 2021, marking an increase of approximately 7.9%[177]. Dividends and Shareholder Information - The company plans to distribute a cash dividend of RMB 0.18 per share, totaling RMB 18,000,000.00 based on 100 million shares, subject to shareholder approval[6]. - The total dividend amount (including tax) was 18,000,000.00, which accounts for 18.50% of the net profit attributable to ordinary shareholders[125]. - The total shares held by the chairman and general manager, Zhang Wensheng, remained unchanged at 6,300,000 shares throughout the reporting period[96]. - The largest shareholder, Zhang Wensheng, holds 63,000,000 shares, representing 63% of the total shares[152]. Market and Industry Insights - In 2021, the market size of China's oral care products industry reached CNY 52.173 billion, with a year-on-year growth of 4.56%[33]. - The oral care products market in China is expected to grow at a CAGR of 6.5%, reaching CNY 64 billion by 2026[36]. - The mouthwash market experienced a compound annual growth rate (CAGR) of 45.69% from 2017 to 2021, reaching a market size of CNY 2.503 billion in 2021[35]. - The electric toothbrush market achieved a CAGR of 27.27% from 2017 to 2021, with a market size of CNY 9.015 billion in 2021[35]. Research and Development - The company has over 200 R&D and technical personnel, with more than 220 patents, indicating strong research and development capabilities[45]. - Research and development expenses rose by 14.53% to CNY 36,287,737.48, indicating a focus on innovation[52]. - The company is investing 50 million in R&D for new technologies aimed at enhancing product efficiency[107]. Risk Management - The company has outlined potential risks in its annual report, advising investors to pay attention to these risks[7]. - The company faces risks from fluctuations in raw material prices, particularly those linked to international oil prices[89]. - The company is exposed to market competition risks due to the low entry barriers in the oral care products industry[89]. Corporate Governance - The company has conducted 2 shareholder meetings, 7 board meetings, and 5 supervisory meetings during the reporting period, ensuring compliance with governance standards[92]. - The company maintains a competitive compensation policy to support a stable management team and fulfill its social responsibilities[93]. - The company has established a comprehensive internal control system to enhance decision-making efficiency and ensure compliance with legal regulations[130]. Environmental and Social Responsibility - The company invested 136.62 million yuan in environmental protection during the reporting period[132]. - The company reduced carbon emissions by 3,317 tons through measures such as using clean energy and establishing photovoltaic power stations[134]. Future Outlook - The company provided guidance for the next fiscal year, projecting revenue growth of 25% to $187.5 million[99]. - The company plans to develop new products and projects to meet market and customer demands, thereby increasing revenue[87]. - Overall, the company remains optimistic about future growth, citing strong demand and a robust product pipeline[99].

2022 年第三季度报告 证券代码：603059 证券简称：倍加洁 倍加洁集团股份有限公司 2022 年第三季度报告 1 / 12 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 | 项目 | 本报告期 | 本报告期比 上年同期增 | 年初至报告期末 | 年初至报告期 末比上年同期 | | | --- | --- | --- | --- | --- | --- | | | | 减变动幅度 | | 增减变动幅度 | | | | | (%) | | (%) | | | 营业收入 | 283,136,319.95 | 66.45 | 755,863,748.47 | | 4.03 ...

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 472,727,428.52, a decrease of 15.05% compared to CNY 556,461,304.29 in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2022 was CNY 18,637,575.43, down 58.42% from CNY 44,822,458.23 in the previous year[19]. - The net cash flow from operating activities decreased by 65.51%, amounting to CNY 31,430,335.09 compared to CNY 91,141,646.65 in the same period last year[19]. - Basic earnings per share for the first half of 2022 were CNY 0.19, a decrease of 57.78% from CNY 0.45 in the same period last year[20]. - The weighted average return on net assets was 1.71%, down 2.56 percentage points from 4.27% in the previous year[20]. - The company reported a decrease of 52.72% in net profit after deducting non-recurring gains and losses, amounting to CNY 19,191,912.58 compared to CNY 40,587,835.44 last year[19]. - The total impact of non-operating income after tax was reported as -554,337.15, reflecting challenges in the financial performance[23]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion in the first half of 2022, representing a 20% year-over-year growth[74]. - The company provided a positive outlook for the next quarter, projecting a revenue increase of 25% based on current market trends and user engagement[76]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,650,340,048.21, reflecting a 7.08% increase from CNY 1,541,167,018.23 at the end of the previous year[19]. - The total liabilities of the company were CNY 563,769,042.41, compared to CNY 461,946,630.81 at the beginning of the period, which is an increase of about 22.0%[94]. - The company's current assets totaled CNY 590,306,530.52, up from CNY 494,119,680.49, indicating an increase of about 19.5%[92]. - Short-term borrowings increased to CNY 179,336,816.76 from CNY 132,921,227.45, representing a rise of about 35.0%[93]. - The total owner's equity at the end of the reporting period is approximately CNY 890.95 million, a decrease from CNY 909.04 million at the beginning of the period, reflecting a reduction of about 2.0%[118]. Market and Product Development - The company is engaged in the research, production, and sales of oral care products and disposable hygiene products, including toothbrushes, toothpaste, and wet wipes[24]. - The product line includes various toothbrushes with features such as antibacterial bristles and ergonomic designs aimed at different consumer demographics[25]. - The company plans to expand its market presence through innovative product development and strategic marketing initiatives[24]. - Future outlook includes a focus on technological advancements in product features to meet evolving consumer needs[24]. - The company focuses on product research and development as a core competitive advantage, emphasizing ODM and its own brands[28]. - The company plans to continue its dual business model of "OEM + own brand" to strengthen its market position[44]. Research and Development - The company increased R&D expenses by 42.51% to CNY 20,053,590.62, focusing on high-end wet wipes and oral care products[50]. - The company has over 220 patents and a strong R&D team of more than 200 personnel, enhancing its innovation capabilities[39]. - The company plans to invest 50 million in research and development for new technologies in the upcoming year[77]. Governance and Compliance - There are no significant risks or non-operating fund occupation issues reported by the controlling shareholder or related parties[5]. - The company has committed to not engaging in any business that competes with its listed company and its subsidiaries, ensuring no conflicts of interest[73]. - The company has not disclosed any new employee stock ownership plans or other incentive measures during the reporting period[68]. - The company has not reported any new product launches or technological advancements during this period[116]. Cash Flow and Financing - The cash flow from operating activities decreased by 65.51% to CNY 31,430,335.09, primarily due to increased material purchases and expenses[50]. - The company reported a net cash flow from financing activities of -12,218,754.14 RMB, contrasting with a positive net flow of 69,799,569.62 RMB in the previous period[109]. - The company generated 1.76 million kWh of electricity from its photovoltaic project in the first half of 2022, saving 670 tons of standard coal and reducing carbon emissions by approximately 1,304 tons[70]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period was 7,530[84]. - The largest shareholder, Zhang Wensheng, holds 63,000,000 shares, accounting for 63.00% of the total shares[86]. - The company did not report any changes in share capital structure during the reporting period[83]. Industry Trends - The overall oral care market in China is projected to grow at a compound annual growth rate (CAGR) of 6.5%, reaching 64 billion CNY by 2026[34]. - The mouthwash market size was 2.5 billion CNY in 2021, with expectations to grow to 6.5 billion CNY by 2026[34]. - The toothbrush market in China had a sales revenue of 27.45 billion CNY in 2021, showing a year-on-year decrease of 1.9%[32]. - The export volume of toothbrushes reached 5.17 billion units in 2021, marking a year-on-year growth of 3.0%[32]. Financial Reporting and Accounting Policies - The company has maintained its accounting policies in accordance with the relevant Chinese accounting standards, ensuring the financial statements reflect a true and complete picture of its financial status[124]. - The company’s financial statements are prepared based on a continuous operating basis, indicating stable operational performance[123]. - The company recognizes revenue when control of goods or services is transferred to the customer, which is determined by the ability to direct the use and obtain almost all economic benefits[187].

Financial Performance - The company's revenue for Q1 2022 was ¥212,518,082.38, representing a decrease of 23.79% compared to the same period last year[5] - The net profit attributable to shareholders was -¥37,727.92, a decline of 100.15% year-on-year[5] - The company reported a net loss for Q1 2022, with operating income not covering total costs[18] - In Q1 2022, the company reported a net profit of -37,727.92, a significant decrease compared to the net profit of 24,742,071.43 in Q1 2021[20] - The company's operating profit for Q1 2022 was -2,243,545.90, a decline from the operating profit of 29,207,134.62 in the same period last year[22] - The company’s total comprehensive income for Q1 2022 was 235,282.20, compared to 25,138,083.52 in Q1 2021, indicating a significant decline[20] - The basic and diluted earnings per share for Q1 2022 were both 0.00, compared to 0.25 in Q1 2021[20] Cash Flow and Liquidity - The net cash flow from operating activities was ¥40,855,933.42, up 49.18% year-on-year[5] - Cash flow from operating activities generated a net amount of 40,855,933.42 in Q1 2022, compared to 27,387,207.48 in Q1 2021, indicating a growth of about 49.4%[22] - The company experienced a net cash outflow from investing activities of -25,248,452.63 in Q1 2022, worsening from -8,192,426.87 in Q1 2021[23] - Cash and cash equivalents at the end of Q1 2022 totaled 100,629,460.49, down from 196,763,188.28 at the end of Q1 2021, a decrease of approximately 48.9%[23] - The company's cash and cash equivalents increased by 45.40%, mainly due to an increase in customer prepayments[8] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,590,702,612.18, an increase of 3.21% from the end of the previous year[5] - Total assets as of March 31, 2022, were RMB 1,590,702,612.18, compared to RMB 1,541,167,018.23 at the end of 2021[15] - Total liabilities increased to RMB 508,957,808.79 from RMB 461,946,630.81 year-over-year[16] - Shareholders' equity as of March 31, 2022, was RMB 1,081,744,803.39, slightly up from RMB 1,079,220,387.42 at the end of 2021[16] Revenue and Costs - Total operating revenue for Q1 2022 was RMB 212,518,082.38, a decrease of 23.7% compared to RMB 278,849,110.05 in Q1 2021[18] - Total operating costs for Q1 2022 were RMB 215,439,448.14, down 14.5% from RMB 252,008,771.64 in Q1 2021[18] - The company's revenue decline was primarily due to a decrease in sales of overseas wet wipes products[8] Research and Development - Research and development expenses increased by 48.85%, attributed to higher salaries for R&D personnel and increased direct material costs[8] - Research and development expenses increased to 10,709,574.22 in Q1 2022 from 7,194,735.22 in Q1 2021, reflecting a growth of approximately 48.5%[22] Investments - The company reported a significant increase of 223.14% in fair value gains, mainly from investment funds and other non-current financial assets[8] - The company reported a total investment income of 3,415,551.18 in Q1 2022, down from 5,419,722.30 in Q1 2021, reflecting a decrease of approximately 37%[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,454[9]

Financial Performance - The company's operating revenue for 2021 was CNY 1,038,587,042.22, representing a 25.47% increase compared to CNY 827,733,643.72 in 2020[22]. - The net profit attributable to shareholders of the listed company decreased by 2.73% to CNY 74,782,577.41 from CNY 76,884,746.92 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 32,113,156.98, a significant decrease of 56.49% compared to CNY 73,811,790.09 in 2020[22]. - Cash flow from operating activities was CNY 57,119,822.51, down 52.71% from CNY 120,779,395.68 in the previous year[22]. - The total assets of the company increased by 15.22% to CNY 1,541,167,018.23 from CNY 1,337,546,848.07 in 2020[23]. - The net assets attributable to shareholders of the listed company rose by 5.10% to CNY 1,079,220,387.42 from CNY 1,026,858,505.88 in the previous year[23]. - The basic earnings per share for 2021 was CNY 0.75, down 2.60% from CNY 0.77 in 2020[24]. - The weighted average return on equity decreased to 7.10% in 2021 from 8.10% in 2020, a drop of 1 percentage point[24]. - The gross margin for personal care products was 20.56%, a decrease of 2.39 percentage points compared to the previous year[61]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion in 2021, representing a growth of 15% year-over-year[108]. Sales and Market Performance - Overseas sales revenue reached CNY 693,627,115.93, accounting for 66.80% of total revenue, while domestic sales were CNY 344,824,570.14, making up 33.20%[33]. - Oral care product sales grew by 13.10%, while wet wipes sales increased by 44.60% year-on-year[59]. - The company’s overseas revenue increased by 32.72% year-on-year, primarily driven by the growth in wet wipes sales[61]. - The domestic oral care market is projected to grow at a compound annual growth rate (CAGR) of 9.3%, reaching 63 billion yuan by 2024[39]. - The toothbrush market is projected to grow at a CAGR of over 10% in the next five years, indicating significant market potential[89]. - The company is focusing on expanding its market channels and brand presence, leveraging its product innovation to capture a larger share of the oral care market[47]. Product Development and Innovation - The company is actively seeking external investment opportunities and has strategically invested in WeiMeiZi Company to enhance its growth strategy[33]. - The company plans to continue expanding its oral care product matrix, with significant growth in mouthwash and wet wipes segments[33]. - In 2021, the company launched multiple new products including mouthwash, oral spray, and dental irrigators as part of its R&D efforts[35]. - The company reported a significant increase in product adoption, particularly in the electric toothbrush segment, which features a magnetic levitation motor capable of reaching 35,000 vibrations per minute[43]. - The new children's toothpaste line includes low-fluoride options designed for safety during the transition from baby teeth to adult teeth, enhancing oral health during this critical period[44]. - The company has expanded its product range to include various types of dental floss and interdental brushes, catering to a broader consumer base and enhancing market presence[44]. - The company plans to enrich its oral care product line, actively developing toothpaste, electric toothbrushes, and oral irrigators to optimize product structure and enhance brand value[94]. Corporate Governance and Management - The board of directors confirmed that all members attended the board meeting, ensuring the authenticity and completeness of the annual report[4]. - The company has established a sound corporate governance structure, ensuring clear responsibilities and checks among its governing bodies[100]. - The company has a remuneration and assessment committee that reviews the compensation of directors and senior management[112]. - The company has implemented a cash dividend policy, ensuring that at least 10% of the distributable profits are allocated as cash dividends each year, provided there are no major capital expenditures[128]. - The company is committed to enhancing its internal control management processes to ensure compliance and operational stability[101]. - The company has maintained a stable management team with no changes in key positions during the reporting period[107]. Environmental and Social Responsibility - In 2021, the company generated 1.59 million kWh of electricity from its 2.6 MW solar power project, saving 605 tons of standard coal and reducing carbon emissions by approximately 1,178 tons[140]. - The company established a special task force for environmental compliance and conducted comprehensive evaluations to ensure legal and regulatory adherence following the environmental incident[139]. - The company actively participates in social welfare initiatives, focusing on supporting underprivileged communities and charitable donations[141]. Risks and Challenges - The company faces risks from fluctuations in raw material prices, particularly those linked to international oil prices, which could impact profitability[97]. - The company is exposed to market competition risks due to the low entry barriers in the oral care industry, which may affect market share if product quality and service levels do not meet customer expectations[97]. - The company is at risk from exchange rate fluctuations, as its main settlement currency for exports is USD, which could affect sales prices[98]. Future Outlook - The company provided a positive outlook for 2022, projecting a revenue growth of 20% based on new product launches and market expansion strategies[108]. - The company plans to expand its overseas market presence, particularly in Southeast Asia and South America, leveraging ODM product sales advantages to meet the growing demand for oral care products and wet wipes[94]. - The company is considering strategic acquisitions to enhance its market position, with a budget of 500 million RMB allocated for potential deals[145].

Financial Performance - The company's revenue for Q1 2022 was CNY 212,518,082.38, representing a decrease of 23.79% compared to the same period last year[5] - The net profit attributable to shareholders was CNY -37,727.92, a decline of 100.15% year-on-year[5] - The net profit after deducting non-recurring gains and losses was CNY 2,793,714.61, down 87.97% from the previous year[5] - The company reported a net loss for Q1 2022, with total operating costs exceeding total operating revenue[18] - In Q1 2022, the company reported a net profit of -37,727.92, a significant decrease compared to a net profit of 24,742,071.43 in Q1 2021[20] - Operating profit for Q1 2022 was -2,243,545.90, contrasting with an operating profit of 29,207,134.62 in the same period last year[22] - The total comprehensive income for Q1 2022 was 235,282.20, a sharp decline from 25,138,083.52 in the same quarter of the previous year[20] Cash Flow and Liquidity - The net cash flow from operating activities increased by 49.18% to CNY 40,855,933.42[5] - Cash flow from operating activities was 40,855,933.42, an increase from 27,387,207.48 in Q1 2021, representing a growth of approximately 49.5%[22] - The company is focusing on improving cash flow management and reducing accounts receivable to enhance liquidity[12] - The company reported a cash and cash equivalents balance of 100,629,460.49 at the end of Q1 2022, down from 196,763,188.28 at the end of Q1 2021[23] - Cash and cash equivalents as of March 31, 2022, amounted to RMB 118,055,771.83, an increase from RMB 81,194,630.54 at the end of 2021[14] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,590,702,612.18, an increase of 3.21% from the end of the previous year[5] - Total assets as of March 31, 2022, were RMB 1,590,702,612.18, compared to RMB 1,541,167,018.23 at the end of 2021[15] - Total liabilities increased to RMB 508,957,808.79 from RMB 461,946,630.81 at the end of 2021, marking an increase of 10.2%[16] - Shareholders' equity as of March 31, 2022, was RMB 1,081,744,803.39, slightly up from RMB 1,079,220,387.42 at the end of 2021[16] Operating Costs and Expenses - The company experienced a 25.53% decline in operating costs, primarily due to decreased sales[8] - Total operating costs for Q1 2022 were RMB 215,439,448.14, down 14.5% from RMB 252,008,771.64 in Q1 2021[18] - Research and development expenses increased by 48.85%, attributed to higher salaries for R&D personnel and increased material costs[8] - The company incurred research and development expenses of 10,709,574.22, compared to 7,194,735.22 in the previous year, reflecting a 48.5% increase[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,454[10] - The company's basic and diluted earnings per share were both CNY 0.00, reflecting a 100% decrease[5] - Basic and diluted earnings per share were both 0.00 in Q1 2022, compared to 0.25 in Q1 2021[20]

Financial Performance - The company's revenue for Q3 2021 was ¥170,101,936.14, a decrease of 26.63% compared to the same period last year[4] - The net profit attributable to shareholders was a loss of ¥4,377,832.76, down 119.17% year-on-year[4] - The net profit excluding non-recurring gains and losses was ¥2,434,707.03, a decrease of 88.69% compared to the previous year[4] - Basic and diluted earnings per share were both -¥0.04, a decrease of 117.39% compared to the same period last year[5] - The net profit for Q3 2021 was CNY 40,444,625.47, a decrease of 43.5% compared to CNY 71,935,380.77 in Q3 2020[20] - Total operating profit for Q3 2021 was CNY 53,128,813.47, down 42.3% from CNY 92,104,852.26 in Q3 2020[22] - The total comprehensive income for Q3 2021 was CNY 42,370,855.75, a decrease of 39.2% from CNY 69,676,148.94 in Q3 2020[20] Year-to-Date Performance - The company reported a 23.00% increase in revenue year-to-date, primarily due to increased sales in overseas markets[9] - The net profit attributable to shareholders decreased by 43.78% year-to-date, mainly due to increased operational costs in the e-commerce business and impacts from the COVID-19 pandemic[9] - Total operating revenue for the first three quarters of 2021 reached ¥726,563,240.43, an increase of 22.9% compared to ¥590,694,543.48 in the same period of 2020[18] - Cash flow from operating activities for the first nine months of 2021 was CNY 154,236,029.39, an increase of 39.7% from CNY 110,397,585.59 in the previous year[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,469,483,392.24, an increase of 9.86% from the end of the previous year[5] - Current assets as of September 30, 2021, totaled ¥754,545,342.86, an increase from ¥711,629,567.32 at the end of 2020[14] - Total liabilities increased to ¥424,254,030.61 from ¥310,688,342.19 year-over-year[16] - The company's cash and cash equivalents were ¥132,727,349.23, down from ¥160,583,463.83 at the end of 2020[14] - Inventory levels rose to ¥154,365,342.99, compared to ¥117,897,728.49 at the end of 2020, reflecting a 30.9% increase[14] - Long-term equity investments increased to ¥92,228,868.72 from ¥82,350,881.56 year-over-year[14] - The company's retained earnings as of September 30, 2021, were ¥401,428,744.44, up from ¥384,984,118.97 at the end of 2020[16] Operational Efficiency - The company reported a net profit margin improvement, with net profit for the first three quarters of 2021 reflecting operational efficiency gains[18] - The company's total liabilities increased, with a significant rise in financial expenses, particularly interest expenses, which reached CNY 2,714,933.62 compared to CNY 540,092.66 in the previous year[22] Research and Development - Research and development expenses increased to CNY 20,664,225.29, up 85.5% from CNY 11,162,853.31 in the same period last year[22] - The company plans to continue investing in R&D and market expansion to drive future growth despite the current financial challenges[24]

Financial Performance - The company's operating revenue for the first half of 2021 reached ¥556,461,304.29, representing a 55.06% increase compared to ¥358,858,041.67 in the same period last year[20]. - The net profit attributable to shareholders for the first half of 2021 was ¥44,822,458.23, a decrease of 8.70% from ¥49,093,245.28 in the previous year[20]. - The basic earnings per share for the first half of 2021 was ¥0.45, down 8.16% from ¥0.49 in the same period last year[20]. - The net cash flow from operating activities increased by 42.92% to ¥91,141,646.65, compared to ¥63,771,362.74 in the previous year[20]. - The total profit for the first half of 2021 was ¥50,769,254.06, compared to ¥60,233,020.00 in the same period of 2020, reflecting a decline of 16%[104]. - The company reported a significant increase in revenue, achieving a net profit margin of 20% for the first half of 2021[79]. - The company has provided a positive outlook for the next quarter, projecting a revenue growth of 10% to 15%[79]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,560,660,535.87, reflecting a 16.68% increase from ¥1,337,546,848.07 at the end of the previous year[20]. - Total liabilities rose to CNY 511,778,250.41, compared to CNY 310,688,342.19 at the end of 2020, indicating an increase of about 64.73%[97]. - Current liabilities increased significantly to CNY 488,996,249.99 from CNY 290,382,743.98, marking a rise of approximately 68.5%[96]. - The total amount of guarantees provided to subsidiaries during the reporting period is 225,000,000 RMB[83]. - The total amount of guarantees (including those to subsidiaries) is 139,000,000 RMB, which accounts for 13.25% of the company's net assets[83]. Market and Product Development - The company specializes in the research, production, and sales of oral hygiene products and disposable sanitary products, including toothbrushes, dental floss, and wet wipes[25]. - The company is focused on expanding its market presence through innovative product development and strategic marketing initiatives[25]. - The domestic oral care market is expected to grow at a compound annual growth rate (CAGR) of 9.3% over the next five years, reaching a market size of 63 billion yuan by 2024[36]. - The company plans to enhance its product offerings by incorporating probiotics and other beneficial ingredients in its toothpaste line[28]. - The company has established a comprehensive marketing network to support its brand value and product development, enhancing its market presence[31]. Research and Development - The company has over 180 R&D and technical personnel and holds more than 220 patents, indicating strong research and development capabilities[42]. - Research and development expenses surged by 129.61% to ¥14,071,931.37, up from ¥6,128,709.01, reflecting increased investment in R&D personnel and materials[51]. - The company is actively integrating its R&D team to align with market trends and improve organizational structure[47]. - The company focuses on product research and design as its core competitive advantage, emphasizing ODM and its own brand, "Bai Jia Jie," which has been recognized as a famous trademark in Jiangsu Province for several consecutive years[30][31]. Risk Management - The company faces risks from fluctuations in raw material prices, particularly those linked to international oil prices, which could impact profitability[57]. - The company is exposed to market competition risks due to low industry entry barriers, with many small-scale producers competing in the oral care market[58]. - The company is at risk from potential decreases in export tax rebate rates, which could adversely affect its foreign sales business[60]. Corporate Governance - The company did not propose any profit distribution plan or capital reserve transfer to increase share capital during the reporting period[5]. - The company has committed to maintaining a cash dividend policy, distributing no less than 10% of the annual distributable profit to shareholders, after reserving statutory and surplus reserves[73]. - The company has established a long-term commitment to avoid and minimize related party transactions, ensuring fairness and transparency in any unavoidable transactions[74]. - The company has not engaged in any business that competes or may compete with its subsidiaries during the reporting period[71]. Financial Policies and Accounting - The financial statements are prepared based on the going concern principle, ensuring no significant doubts about the company's ability to continue operations within the next 12 months[132]. - The accounting policies comply with the Chinese Accounting Standards, reflecting the company's financial position and operating results accurately[133]. - The company recognizes revenue when control of goods or services is transferred to customers, indicating the fulfillment of performance obligations[199]. - The company estimates expected credit losses for financial assets measured at amortized cost and those measured at fair value, considering past events, current conditions, and future economic forecasts[156].

Financial Performance - Operating revenue surged by 121.36% to CNY 278,849,110.05 year-on-year[5] - Net profit attributable to shareholders rose by 76.60% to CNY 24,742,071.43 compared to the same period last year[5] - Basic earnings per share increased by 78.57% to CNY 0.25[6] - The company reported a net profit excluding non-recurring gains and losses of CNY 23,227,634.53, a 46.13% increase year-on-year[5] - Total operating revenue for Q1 2021 reached ¥278,849,110.05, a significant increase of 121.5% compared to ¥125,972,108.90 in Q1 2020[23] - Net profit for Q1 2021 was ¥24,742,071.43, representing a 76.3% increase from ¥14,009,911.84 in Q1 2020[24] - Operating profit for Q1 2021 was ¥29,207,134.62, an increase of 33.2% compared to ¥21,940,657.93 in Q1 2020[24] - Total comprehensive income for Q1 2021 was ¥25,138,083.52, up 77.5% from ¥14,152,764.82 in Q1 2020[25] - The total profit for Q1 2021 was ¥28,958,556.45, which is an increase of 73.5% from ¥16,675,193.23 in Q1 2020[24] Cash Flow and Liquidity - Net cash flow from operating activities improved significantly to CNY 27,387,207.48 from a negative CNY 752,465.45 in the previous year[5] - The net cash flow from operating activities was ¥27.39 million in Q1 2021, recovering from a negative cash flow of ¥0.75 million in Q1 2020[28] - The total cash inflow from investment activities was ¥51.70 million in Q1 2021, down 81% from ¥273.06 million in Q1 2020[29] - The net cash flow from investment activities was negative at ¥8.19 million in Q1 2021, compared to a positive cash flow of ¥4.27 million in Q1 2020[29] - The cash inflow from financing activities was ¥100.75 million in Q1 2021, a substantial increase from ¥35.08 million in Q1 2020[29] - The net cash flow from financing activities was ¥95.41 million in Q1 2021, compared to ¥29.79 million in Q1 2020[29] - The total cash and cash equivalents at the end of Q1 2021 reached ¥196.76 million, up from ¥102.52 million at the end of Q1 2020[29] Assets and Liabilities - Total assets increased by 13.00% to CNY 1,511,365,611.20 compared to the end of the previous year[5] - The total current assets amounted to CNY 843,365,339.97, up from CNY 711,629,567.32 at the end of the previous year[16] - The company's total liabilities increased significantly, reflecting the growth in operational scale and financing needs[12] - Current liabilities rose to ¥436,898,536.77 from ¥290,382,743.98, marking an increase of about 50.5%[17] - Non-current liabilities totaled ¥22,470,485.03, up from ¥20,305,598.21, indicating an increase of approximately 10.7%[18] - Total liabilities increased to ¥459,369,021.80 from ¥310,688,342.19, representing a growth of about 47.9%[18] Shareholder Information - The total number of shareholders reached 6,607 at the end of the reporting period[10] - The largest shareholder, Zhang Wensheng, holds 63.00% of the shares[10] Expenses - Operating costs surged by 134.46% to CNY 218,663,610.35, reflecting higher sales and previous pandemic-related impacts[12] - Research and development expenses increased by 190.28% to CNY 7,194,735.22, attributed to higher material costs and personnel expenses[12] - The company reported a total operating cost of ¥252,008,771.64 in Q1 2021, which is an increase of 127.5% from ¥110,876,389.12 in Q1 2020[23] Other Income and Losses - The company received government subsidies amounting to CNY 2,493,839.57 related to its normal business operations[7] - Other income for Q1 2021 was ¥2,493,839.57, a substantial increase from ¥56,191.46 in the previous year[23] - The company experienced a foreign exchange loss of ¥2,103,235.94 in Q1 2021, compared to a gain of ¥134,831.31 in Q1 2020[23]

Financial Performance - The company's operating revenue for 2020 was RMB 827,733,643.72, representing a 2.70% increase compared to RMB 805,994,374.65 in 2019[21]. - The net profit attributable to shareholders for 2020 was RMB 76,884,746.92, a decrease of 29.70% from RMB 109,365,718.83 in 2019[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 73,811,790.09, down 26.36% from RMB 100,229,378.79 in 2019[21]. - The net cash flow from operating activities was RMB 120,779,395.68, a decline of 25.06% compared to RMB 161,177,819.56 in 2019[21]. - Basic earnings per share decreased by 29.36% to CNY 0.77 in 2020 compared to CNY 1.09 in 2019[22]. - The company's weighted average return on equity fell to 8.10% in 2020, down from 11.86% in 2019, a decrease of 3.76 percentage points[22]. - The total amount of trading financial assets decreased by CNY 76,884,391.42 from the beginning to the end of 2020[30]. - The net cash flow from operating activities decreased by 25.06% to ¥120,779,395.68 in 2020 from ¥161,177,819.56 in 2019, primarily due to an increase in accounts receivable and prepayments to suppliers for raw materials[73]. - The net cash flow from investing activities improved by 25.76%, with a net outflow of ¥114,182,606.04 in 2020 compared to ¥153,794,675.86 in 2019, attributed to a reduction in the scale of investments[73]. - The net cash flow from financing activities turned positive at ¥6,276,748.51 in 2020, a significant improvement from a negative cash flow of ¥32,863,653.17 in 2019, mainly due to increased short-term borrowings[73]. Assets and Liabilities - The total assets at the end of 2020 were RMB 1,337,546,848.07, an increase of 12.18% from RMB 1,192,347,439.15 at the end of 2019[21]. - The total liabilities and equity increased by 5.62% to 1,026,858,505.88 RMB[60]. - The total liabilities of Beijia Group as of December 31, 2020, were RMB 310,688,342.19, compared to RMB 220,117,186.28 in 2019, indicating an increase of about 41.0%[168][169]. - Cash and cash equivalents increased by 94.56% to ¥160,583,463.83, up from ¥82,538,476.61 in the previous year, primarily due to an increase in time deposits[75]. - Accounts receivable rose by 30.02% to ¥152,362,273.58, up from ¥117,182,207.93, driven by increased sales in the wet wipes business[75]. - Inventory remained relatively stable, with a slight increase of 0.64% to ¥117,897,728.49 from ¥117,143,909.04[75]. - The company's long-term equity investments increased to RMB 82,350,881.56 in 2020 from RMB 77,163,774.22 in 2019, indicating a growth of approximately 6.5%[167]. - The short-term borrowings surged to RMB 32,638,280.38 in 2020 from RMB 5,508,612.39 in 2019, reflecting a significant increase of approximately 492.5%[168]. Dividend Policy - The company plans to distribute a cash dividend of RMB 2.40 per 10 shares, totaling RMB 24,000,000.00, subject to shareholder approval[5]. - The cash dividend distribution policy emphasizes a minimum of 10% of the distributable profit to be paid out as cash dividends, provided there are no significant capital expenditures planned[102]. - The company reported a net profit of 76.88 million RMB for 2020, with a cash dividend payout ratio of 31.22%[104]. - The company has committed to avoiding any business activities that may compete with its subsidiaries, ensuring no conflicts of interest arise[105]. - The total cash dividends distributed over the last three years were 24 million RMB in 2020, 20 million RMB in 2019, and 8.8 million RMB in 2018[104]. Market and Product Development - The company primarily engages in the research, production, and sales of oral hygiene products and disposable sanitary products[32]. - The company is expanding its product line to include various types of dental floss and inter-dental brushes, catering to a wide range of consumer needs[37]. - The company aims to enhance market presence through the introduction of new products and technologies in the oral care segment[33]. - The company is actively pursuing market expansion strategies to increase its footprint in the oral care industry[33]. - The company is focused on developing innovative oral care solutions, including probiotics and vitamin C formulations for enhanced dental health[36]. - The company plans to enhance its production efficiency by increasing and expanding new production lines and improving automation levels[90]. - The company intends to explore overseas markets, particularly in Southeast Asia and South America, to meet the growing demand for oral care products and wet wipes[93]. Risks and Challenges - The company has outlined potential risks in its annual report, advising investors to pay attention to these risks[6]. - The decline in net profit was attributed to increased material costs, higher management expenses, and production losses due to the pandemic[22]. - The company faces risks from raw material price fluctuations, as key materials are linked to international oil prices, which can significantly impact profitability[96]. - The company is exposed to exchange rate fluctuations and potential reductions in export tax rebates, which could adversely affect its overseas business[99]. Governance and Compliance - The company has maintained a standard unqualified audit opinion from its accounting firm, ensuring the accuracy and completeness of its financial reports[4]. - The company has established a comprehensive quality control system and holds multiple international certifications, ensuring product quality and stability[50]. - The company has a well-defined governance structure that effectively protects the interests of shareholders and stakeholders[150]. - The independent directors participated fully in board meetings and shareholder meetings, ensuring accountability[151]. - The company has no significant litigation or arbitration matters during the reporting period[113]. Research and Development - Research and development expenses rose by 46.77% to 19,306,975.93 RMB, accounting for 2.33% of operating revenue[71]. - The R&D team consists of over 180 personnel, with more than 220 patents, supporting continuous product development and innovation[50]. - The company is investing in new technology development, allocating $10 million for R&D in the upcoming quarter[140].